A team of researchers led by Dr. Kim V. Narry, director of the Center for RNA Research at the Institute for Basic Science ...

Analysts have set 12-month price targets for Millicom Intl Cellular, revealing an average target of $35.98, a high estimate ...

Florey researchers have engineered a way to fool the immune system into accepting neural grafts as part of the body, rather ...

For patients with polycystic kidney disease (PKD), a common genetic disorder that ravages the waste-removing organ with cysts ...

Frequent distressing dreams are linked to faster biologic aging and an increased risk for premature death, independent of ...

Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report)‘s stock had its “neutral” rating reaffirmed by research analysts at ...

I’ve used iPad Pro as my primary computer for a decade, and despite being Mac-curious, here’s why I need to stick with the iPad (for now).

Researchers are studying why the energy factories are moving between cells and whether the process can be harnessed to treat ...

Verizon and the Green Bay Packers are helping clear veterans' debt as part of a new seven-year partnership agreement. The ...

Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth, discusses strategies for managing costs of novel cellular and gene therapies in the oncology pipeline.

Damage to the genetic material of mitochondria – the mitochondrial DNA or mtDNA for short – can lead to diseases such as Parkinson's, Alzheimer's, amyotrophic lateral sclerosis (ALS), cardiovascular ...

One study from the“Cellular Health & Longevity Institute” reported that daily use of Mitolyn's key ingredients Increased ...